Researchers from the Department of Clinical Oncology, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong ...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage ...
PHILADELPHIA — (Jan. 17, 2022) — A new study by researchers at The Wistar Institute, an international biomedical research leader ...
A new analysis of data from U.S. military recruits suggests multiple sclerosis (MS) – a disease considered of unknown etiology ...
Boston, MA – Multiple sclerosis (MS), a progressive disease that affects 2.8 million people worldwide and for which there is no ...
PHILADELPHIA — (Jan. 5, 2022) — The Wistar Institute announces the initiation of a Phase 2 clinical study of VK-2019 ...
